Nov 6, 2025 06:35AM Stevanato Group S.p.A. (STVN) Tops Q3 EPS by 1c ; Offers Guidance

Oct 21, 2025 06:31AM Stevanato Group expands drug delivery manufacturing capacity in Germany

Sep 23, 2025 07:29AM KeyBanc Takeaways from This Year's BioProcess International Conference

Aug 5, 2025 01:24PM Stevanato Group S.p.A. (STVN) PT Raised to $32 at Citi

Aug 5, 2025 06:34AM Stevanato Group S.p.A. (STVN) Tops Q2 EPS by 1c ; Offers Guidance

Jul 23, 2025 06:30AM Stevanato Group secures €200 million financing for expansion projects

Jun 18, 2025 09:50AM KeyBanc on the Potential Breakout Year for GLP-1 Beneficiaries West Pharmaceutical (WST) and STVN

May 8, 2025 06:41AM Stevanato Group S.p.A. (STVN) Tops Q1 EPS by 1c; offers guidance

Mar 6, 2025 07:35AM Citi Reiterates Buy Rating on Stevanato Group S.p.A. (STVN)

Mar 6, 2025 06:33AM Stevanato Group S.p.A. (STVN) Tops Q4 EPS by 1c ; Offers Guidance

Jan 27, 2025 06:05AM KeyBanc Highlights WST, GXIG, and STVN as GLP-1 Estimates Raise

Dec 23, 2024 05:30AM KeyBanc Weighs in on GLP-1 Injection Leaders Following Latest NVO Results

Dec 13, 2024 06:04AM Wolfe Research Starts Stevanato Group S.p.A. (STVN) at Outperform

Dec 3, 2024 08:00AM Morgan Stanley Assumes Stevanato Group S.p.A. (STVN) at Equalweight

Nov 5, 2024 03:20PM Citi Reiterates Buy Rating on Stevanato Group S.p.A. (STVN)

Nov 5, 2024 06:35AM Stevanato Group S.p.A. (STVN) Misses Q3 EPS by 2c, provides guidance

Sep 26, 2024 07:05AM Stevanato Group S.p.A. (STVN), Gerresheimer and SCHOTT Pharma, Announce Strategic Industry “Alliance for RTU”

Aug 6, 2024 06:39AM Stevanato Group S.p.A. (STVN) Misses Q2 EPS by 1c, provides guidance